Timothy P Hughes (Timothy Hughes)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Venues

British journal of haematology

Leukemia

Leukemia & lymphoma

Blood cancer journal

South Australian Health and Medical Research Institute

University of New South Wales (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

South Australian Health and Medical Research Institute

Australia

Theme Leader :: Precision Medicine Theme

SA Pathology

Australia

Head :: Department of Haematology

SA Pathology

Australia

Consultant Haematologist :: Division of Haematology

Education History

University of New South Wales

Australia

BSC

Publications

Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia 38 (7) (2024)
Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia 38 (7) (2024)
Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia 38 (7) (2024)
Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia (2024)
Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia 38 (7) (2024)
Chung Hoow Kok, Verity A Saunders, Phuong Dang, Naranie Shanmuganathan, Deborah L White, Susan Branford, David Yeung, Timothy P Hughes
Adverse outcomes for chronic myeloid leukemia patients with splenomegaly and low in vivo kinase inhibition on imatinib. Blood cancer journal 13 (1) (2023)
Yazad D Irani, Amy Hughes, Chung Hoow Kok, Jade Clarson, David T O Yeung, David M Ross, Susan Branford, Timothy P Hughes, Agnes S M Yong
Immune modulation in chronic myeloid leukaemia patients treated with nilotinib and interferon-alpha. British journal of haematology (2023)
Liu Lu, Chung Hoow Kok, Phuong Dang, Susan Branford, Verity A Saunders, Naranie Shanmuganathan, David M Ross, Timothy P Hughes, David T O Yeung
Highly sensitive droplet digital polymerase chain reaction for BCR::ABL1 messenger RNA identifies patients with chronic myeloid leukaemia with a low probability of achieving treatment-free remission. British journal of haematology 198 (3) (2022)
Shady Adnan-Awad, Oscar Brück, Naranie Shanmuganathan, Timo Jarvinen, Hanna Lähteenmäki, Jay Klievink, Hazem Ibrahim, Soili Kytölä, Perttu Koskenvesa, Timothy P Hughes, Susan Branford, Matti Kankainen, Mohamed El Missiry
Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation. Blood cancer journal 12 (4) (2022)
Naranie Shanmuganathan, Timothy P Hughes
Asciminib for chronic myeloid leukaemia: Next questions. British journal of haematology 199 (3) (2022)
Monika M Kutyna, Chung Hoow Kok, Yoon Lim, Elizabeth Ngoc Hoa Tran, David Campbell, Sharon Paton, Chloe Thompson-Peach, Kelly Lim, Dimitrios Cakouros, Agnes Arthur, Timothy P Hughes, Sharad Kumar, Daniel Thomas, Stan Gronthos, Devendra K Hiwase
A senescence stress secretome is a hallmark of therapy-related myeloid neoplasm stromal tissue occurring soon after cytotoxic exposure. Leukemia 36 (11) (2022)
Timothy P Hughes, Nelma Cristina D Clementino, Mikhail Fominykh, Jeffrey H Lipton, Anna G Turkina, Elena Beatriz Moiraghi, Franck E Nicolini, Naoto Takahashi, Tomasz Sacha, Dong-Wook Kim, Rafik Fellague-Chebra, Ranjan Tiwari, Catherine Bouard, Francois-Xavier Mahon
Long-term treatment-free remission in patients with chronic myeloid leukemia after second-line nilotinib: ENESTop 5-year update. Leukemia 35 (6) (2021)
Susan L Heatley, Kartini Asari, Caitlin E Schutz, Tamara M Leclercq, Barbara J McClure, Laura N Eadie, Timothy P Hughes, David T Yeung, Deborah L White
In-vitro modeling of TKI resistance in the high-risk B-cell acute lymphoblastic leukemia fusion gene RANBP2-ABL1 - implications for targeted therapy. Leukemia & lymphoma 62 (5) (2021)
David Morrall Ross, Timothy P Hughes
Counterpoint: There is a best duration of deep molecular response for treatment-free remission, but it is patient-specific, and that is the challenge. British journal of haematology 192 (1) (2020)
Barbara J McClure, Susan L Heatley, Jacqueline Rehn, James Breen, Rosemary Sutton, Timothy P Hughes, Ram Suppiah, Tamas Revesz, Michael Osborn, Daniel White, David T Yeung, Deborah L White
High-risk B-cell acute lymphoblastic leukaemia presenting with hypereosinophilia and acquiring a novel PAX5 fusion on relapse. British journal of haematology 191 (2) (2020)
Anna Turkina, Jian-Xiang Wang, Vikram Mathews, Guray Saydam, Chul Won Jung, Hani Hassan Al Hashmi, Mohamed Yassin, Solenn Le Clanche, Darko Miljkovic, Cassandra Slader, Timothy P Hughes
TARGET: a survey of real-world management of chronic myeloid leukaemia across 33 countries. British journal of haematology 190 (6) (2020)
Yazad D Irani, Amy Hughes, Jade Clarson, Chung Hoow Kok, Naranie Shanmuganathan, Deborah L White, David T Yeung, David M Ross, Timothy P Hughes, Agnes S M Yong
Successful treatment-free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells. British journal of haematology 191 (3) (2020)
Ilaria S Pagani, Phuong Dang, Verity A Saunders, Jodi Braley, Angelica Thieleke, Susan Branford, Timothy P Hughes, David Morrall Ross
Clinical utility of genomic DNA Q-PCR for the monitoring of a patient with atypical e19a2 BCR-ABL1 transcripts in chronic myeloid leukemia. Leukemia & lymphoma 61 (10) (2020)
David Morrall Ross, Ilaria S Pagani, Yazad Darius Irani, Jade Clarson, Tamara Leclercq, Phuong Dang, Jennifer McLean, Verity A Saunders, Lisa Carne, John Reynolds, David S Ritchie, Deborah L White, Susan Branford, Timothy P Hughes, Agnes S M Yong
Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia. British journal of haematology 186 (3) (2019)
Timothy P Hughes, Eduardo Munhoz, Marco Aurelio Salvino, Tee Chuan Ong, Alaa Elhaddad, Jake Shortt, Hang Quach, Carolina Pavlovsky, Vernon J Louw, Lee-Yung Shih, Anna G Turkina, Luis Meillon, Yu Jin, Sandip Acharya, Darshan Dalal, Jeffrey H Lipton
Nilotinib dose-optimization in newly diagnosed chronic myeloid leukaemia in chronic phase: final results from ENESTxtnd. British journal of haematology 179 (2) (2017)

Timothy P Hughes.css-eqlu8i{font-size:small;padding-left:4px;} (Timothy Hughes)

Publication Activity (10 Years)

Top Topics

Top Venues

Timothy P Hughes (Timothy Hughes)